UK firm teams up with Incepta on intranasal Covid vaccine

British biomedical firm ViraCorp has joined forces with leading Bangladeshi pharmaceutical company Incepta to develop needle-free Covid-19 vaccine, which uses state-of-the-art intra-nasal technology.
17 December 2021, 18:00 PM

Covid Vaccine Booster doses to be trialled from tomorrow

Covid-19 booster jabs will be administered on trial basis from tomorrow, Health Minister Zahid Maleque said yesterday.
17 December 2021, 18:00 PM

Japan to provide 7 lakh more AstraZeneca vaccines doses Dec 21

A consignment of 704,010 doses of Oxford-AstraZeneca vaccine manufactured in Japan is scheduled to arrive in Bangladesh on December 21.
17 December 2021, 16:26 PM

Covid-19 booster dose trial run from Sunday: health minister

Health and Family Welfare Minister Zahid Maleque said the Covid-19 experimental booster dose would be administered from Sunday.
17 December 2021, 15:02 PM

UK's ViraCorp partners with Incepta to develop nasal Covid-19 vaccine

British biomedical firm, ViraCorp, has joined forces with leading pharmaceutical company, Incepta, to develop a Covid-19 vaccine, which can be administered via one's nose.
17 December 2021, 13:32 PM

Dengue fever: 14 patients hospitalised in 24 hours

At least 14 dengue patients were hospitalised in 24 hours till 8:00 am today, according to the Directorate General of Health Services (DGHS).
17 December 2021, 11:09 AM

2 Covid-19 deaths, 191 cases recorded in 24 hours

Two people died from Covid-19 in 24 hours till 8am today, said a press release issued by the Directorate General of Health Services (DGHS).
17 December 2021, 10:57 AM

US CDC recommends Moderna, Pfizer vaccines over J&J’s

The U.S. Centers for Disease Control and Prevention on Thursday recommended Americans choose to receive one of two other authorised COVID-19 vaccines over Johnson & Johnson's (JNJ.N) shot, due to rare but sometimes fatal cases of blood-clotting.
17 December 2021, 04:55 AM

3 Covid-19 deaths, 257 cases recorded in 24 hours

Three people died from Covid-19 in 24 hours till 8 am today, said a press release issued by the Directorate General of Health Services (DGHS).
16 December 2021, 12:32 PM

17 dengue patients hospitalised in 24 hours

Seventeen dengue patients were hospitalised in 24 hours till 8:00 am today, according to the Directorate General of Health Services (DGHS).
16 December 2021, 10:36 AM

Vaccines may be less effective against Omicron

The World Health Organization yesterday said preliminary evidence indicated that Covid-19 vaccines might be less effective against infection and transmission linked to the Omicron coronavirus variant, a day after a major US study said all three US-authorised vaccines appear to be significantly less protective against the variant.
15 December 2021, 18:00 PM

Covid Booster: Vaccination to begin in 7-10 days

The government will start administering Covid-19 booster shots in the next seven to 10 days, Health Minister Zahid Maleque announced yesterday.
15 December 2021, 18:00 PM

Covid-19 booster dose campaign to begin in 7-10 days: health minister

The government will start administering booster doses of Covid-19 vaccines in the next 7-10 days, said Health Minister Zahid Maleque today.
15 December 2021, 12:23 PM

27 dengue patients hospitalised in 24 hours

Twenty-seven dengue patients were hospitalised in 24 hours till 8:00 am today, according to the Directorate General of Health Services (DGHS).
15 December 2021, 11:13 AM

4 Covid-19 deaths, 297 new cases in 24 hours

Four people died from Covid-19 in 24 hours till 8:00 am today, according to a press release issued by the Directorate General of Health Services (DGHS).
15 December 2021, 10:44 AM

Covid vaccine: Pfizer to displace AstraZeneca as main supplier to poorer countries

Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of Covid-19 vaccines to the global COVAX programme at the start of 2022, a shift that shows the increasing importance of their shot for poorer states.
15 December 2021, 10:01 AM

Pfizer says Covid pill reduces hospital, death risks by nearly 90%

Pfizer Inc yesterday said final analysis of its antiviral Covid-19 pill still showed near 90% efficacy in preventing hospitalisations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.
14 December 2021, 18:00 PM

First protect the unvaccinated

Getting an initial course of Covid-19 vaccines to unprotected groups all over the world should remain a top priority before offering booster shots to vulnerable groups, World Health Organisation (WHO) Emergency Director Mike Ryan said yesterday.
14 December 2021, 18:00 PM

Covid-positive pregnant women 8 times more at risk

Covid-19 poses eight times higher risk of adverse maternal outcomes for pregnant women, a recent study found.
14 December 2021, 18:00 PM

Omicron: South Africa says Pfizer vaccine provides 70% protection against hospitalization

A two-dose Pfizer/BioNTech vaccination provides just 33% protection against infection by the omicron variant of the coronavirus, but 70% protection against hospitalization, according to a large-scale analysis in South Africa released Tuesday.
14 December 2021, 12:04 PM